Abstract
Background: Kentucky has one of the highest mortality rates for colon cancer, despite dramatic improvements in screening. The National Comprehensive Cancer Network (NCCN) guidelines recommend operation and adjuvant chemotherapy for locally advanced (stage IIb/c and stage III) colon cancer (LACC). The purpose of this study was to determine the rate of nonadherence with current standard of care (SOC) and associated factors as possible contributors to mortality. Methods: The Kentucky Cancer Registry database linked with administrative health claims was queried for individuals (20 years and older) diagnosed with LACC from 2007 to 2012. Bivariate and logistic regression of nonadherence was performed. Survival analysis was performed with Cox regression and Kaplan-Meier plots. Results: A total of 1,404 patients with LACC were included. Approximately 42% of patients with LACC were noted to be nonadherent to SOC, with nearly all (95.7%) failing to receive adjuvant chemotherapy. After adjusting for all significant factors, we found the factors associated with nonadherence included the following: age older than 75 years, stage III colon cancer, high Charlson Comorbidity Index (3+), low poverty level, Medicaid coverage, and disability. Adherence to SOC is associated with a significant improvement in the 5-year survival rate compared with nonadherence (63.0% and 27.4%, respectively; p < 0.0001). Conclusions: Our study identified multiple factors associated with the failure of patients with LACC to receive SOC, particularly adjuvant chemotherapy, suggesting the need to focus on improving adjuvant chemotherapy compliance in specific populations. Nonadherence to LACC SOC is likely a major contributor to the persistently high mortality rates in Kentucky.
Original language | English |
---|---|
Pages (from-to) | 428-439 |
Number of pages | 12 |
Journal | Journal of the American College of Surgeons |
Volume | 230 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2020 |
Bibliographical note
Publisher Copyright:© 2020 American College of Surgeons
Funding
Support: Dr Chow is supported by a National Cancer Institute postdoctoral training grant (T32 CA160003). Drs Huang and Chen are supported by the Centers for Disease Control and Prevention (IU48DP005014-07 SIP14-017). Additionally, Dr Huang is supported by a National Cancer Center support grant (P30 CA177558). Assistance with data extraction was accommodated by a National Center for Advancing Translational Sciences grant (UL1 TR001998).The authors would like to acknowledge and thank the Markey Cancer Center Biostatistics and Bioinformatics and Cancer Research Informatics Shared Resource Facilities of the University of Kentucky Markey Cancer Center (supported by National Cancer Institute grant P30 CA177558) for statistical analyses and for obtaining Kentucky CRC patient data and analysis from the Kentucky Cancer Registry, respectively. In addition, we thank the Center for Clinical and Translational Sciences, supported by the National Center for Advancing Translational Sciences grant UL1 TR001998, for assistance with data extraction. Disclaimer: The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the grant funding agencies. Support: Dr Chow is supported by a National Cancer Institute postdoctoral training grant ( T32 CA160003 ). Drs Huang and Chen are supported by the Centers for Disease Control and Prevention ( IU48DP005014-07 SIP14-017). Additionally, Dr Huang is supported by a National Cancer Center support grant ( P30 CA177558 ). Assistance with data extraction was accommodated by a National Center for Advancing Translational Sciences grant ( UL1 TR001998 ). The authors would like to acknowledge and thank the Markey Cancer Center Biostatistics and Bioinformatics and Cancer Research Informatics Shared Resource Facilities of the University of Kentucky Markey Cancer Center (supported by National Cancer Institute grant P30 CA177558 ) for statistical analyses and for obtaining Kentucky CRC patient data and analysis from the Kentucky Cancer Registry, respectively. In addition, we thank the Center for Clinical and Translational Sciences , supported by the National Center for Advancing Translational Sciences grant UL1 TR001998 , for assistance with data extraction.
Funders | Funder number |
---|---|
Kentucky Cancer Registry | |
Centers for Disease Control and Prevention | IU48DP005014-07 SIP14-017 |
National Childhood Cancer Registry – National Cancer Institute | P30 CA177558, T32CA160003 |
National Center for Advancing Translational Sciences (NCATS) | UL1 TR001998 |
National Cancer Center | |
Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston | |
University of Kentucky Markey Cancer Center |
ASJC Scopus subject areas
- Surgery